Merck says 44,000 filed for interim Vioxx injury payouts

NEW YORK (MarketWatch) — Merck & Co. said Monday that more than 44,000 of the approximately 47,000 who registered eligible injuries have
submitted some or all of the materials required for enrollment that
could qualify them for an interim payment in the program to resolve
state and federal myocardial infarction (MI) and ischemic stroke (IS)
claims filed against the company in the United States. If all of these
eligible submissions are completed in accordance with the Settlement
Agreement, this would represent more than 93 percent of the eligible
MI and IS claims previously registered with the program. In addition,
approximately 5,000 other claimants have also sought to enroll and
their eligibility status still has to be determined.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Original post by Forextvblog

Leave a Reply